1. WIP1 phosphatase as pharmacological target in cancer therapy
    Soňa Pecháčková et al, 2017, Journal of Molecular Medicine CrossRef
  2. TRPM2-AS promotes the malignancy of osteosarcoma cells by targeting miR-15b-5p/PPM1D axis
    Yingchun Cai et al, 2022, Cell Cycle CrossRef
  3. The role of PPM1D in cancer and advances in studies of its inhibitors
    Wenhong Deng et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  4. PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma
    Ke Li et al, 2020, Pathology & Oncology Research CrossRef
  5. Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen
    Victor Clausse et al, 2022, ACS Pharmacology & Translational Science CrossRef
  6. Model-based optimization of combination protocols for irradiation-insensitive cancers
    Beata Hat et al, 2020, Scientific Reports CrossRef
  7. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy
    V Clausse et al, 2016, Cell Death & Disease CrossRef
  8. Changes in the Transcriptome Caused by Mutations in the Ribosomal Protein uS10 Associated with a Predisposition to Colorectal Cancer
    Yueming Tian et al, 2022, International Journal of Molecular Sciences CrossRef
  9. Metal-dependent Ser/Thr protein phosphatase PPM family: Evolution, structures, diseases and inhibitors
    Rui Kamada et al, 2020, Pharmacology & Therapeutics CrossRef
  10. PPM1D in Solid and Hematologic Malignancies: Friend and Foe?
    Linda Zhang et al, 2022, Molecular Cancer Research CrossRef
  11. Prognostic and immunological potential of PPM1G in lung adenocarcinoma
    Rongjiang Yin et al, 2023, Molecular Medicine Reports CrossRef
  12. Wip1 phosphatase in breast cancer
    A Emelyanov et al, 2015, Oncogene CrossRef
  13. WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C
    Ya-ling Tang et al, 2015, Oncotarget CrossRef
  14. Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway
    Ping Wang et al, 2016, Oncology Letters CrossRef
  15. WIP1 is a novel specific target for growth hormone action
    Tugce Apaydin et al, 2023, iScience CrossRef
  16. Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma
    Björn Stolte et al, 2018, Journal of Experimental Medicine CrossRef
  17. Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy
    Borahm Kim et al, 2019, PLOS ONE CrossRef
  18. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma
    Yi-Ren Lin et al, 2021, Aging CrossRef
  19. Retraction Note: MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia
    Zhu Xishan et al, 2023, Scientific Reports CrossRef
  20. Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma
    Zhi Xu et al, 2016, Frontiers of Medicine CrossRef
  21. Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
    Maria Chiara Fontana et al, 2021, Biomedicines CrossRef
  22. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer
    Yuka Inoue et al, 2018, Clinical Breast Cancer CrossRef
  23. Recent Advances and Molecular Pathway in Salivary Adenoid Cystic Carcinoma (Review)
    Laijun Xu et al, 2020, Current Signal Transduction Therapy CrossRef
  24. Sensitivity of Cells with Various Levels of Ppm1d Expression to Classical Chemotherapeutic Drugs for Colorectal Cancer Treatment
    E. Yu. Kochetkova et al, 2019, Cell and Tissue Biology CrossRef
  25. Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer
    Rita Nahta et al, 2021, Biochemical Pharmacology CrossRef
  26. Wip1 contributes to the adaptation of HepG2 human liver cancer cells to stress hormone‑induced DNA damage
    Gaoxiang Li et al, 2022, Oncology Letters CrossRef